Research & Education

Episode 1: EGFR Inhibitors as First-line Therapy in Advanced Non-small Cell Lung Cancer

Dr. Roy Herbst, professor of thoracic medical oncology at the University of Texas M.D. Anderson Cancer Center and member of the IASLC speaks with Dr.

Episode 2: IASLC Staging Initiative and What It Means for Lung Cancer Diagnosis and Treatment

Dr. David Gandara, director of the thoracic oncology program at University of California Davis Cancer Center and President-Elect of the IASLC is joined by Dr.

Episode 3: Analyzing Exhaled Breath for the Diagnosis of Lung Cancer

Dr. Fred Hirsch, Professor of Medicine and Pathology at the University of Colorado Denver and board member of the IASLC, is joined by Dr.